Seize AI & Tech Opportunities, Monitor New Risks & Regulations, Embed Controls & Safeguard The Business During Times Of Change
Revolutionise Risk & Compliance Strategies Across Pharma & Life Sciences
2nd Annual, One-Day Sector-Targeted Conference & Networking Exhibition, Central London, 2nd October 2024
08.30 Registration, Informal Networking & GIC Welcome
09.00 Morning Co-Chairs’ Opening Remarks
Christina Dimanova, Regional Compliance & Integrity Officer, Europe region MIDI, Boehringer Ingelheim
Geopolitics & International Risk
09.10 From Elections To Conflict To Sanctions: Increase Your Agility To Adapt & Navigate Through Turbulent Times By Preparing For Changing Risks, Ethical Challenges & The Regulatory Impact Of Operating A Global Pharmaceutical Business In A Divided World
- Planning for operational continuity and ongoing compliance in the face of emerging risks and new regulations in a fast-moving world – how can you craft agile frameworks which allow you to anticipate, react and respond?
- Collaborate with operations to ensure they are aligned with evolving regulations and the international conduct – all while steadfastly upholding ethical standards and prioritising patient needs
- From elections to conflict to sanctions, keep an eye on the geopolitical landscape and understanding exactly what different outcomes could mean for your function
- Remain vigilant in staying updated on regulatory frameworks and ethical conduct throughout the supply chain concerning human rights, corruption, fraud, potential sanctions breaches and anti-terrorism
Ilvija Gruba, Regional Compliance Assurance Director for Middle East and Africa, Privacy & Sanctions, AstraZeneca
AI & Automation- Panel & Q&A
09.30 Design Proactive Regulatory Frameworks, Policies & Codes Of Conduct Around AI To Enable Effective AI Adoption Across All Functions & Protect The Business From Risks
- The challenge we face: creating and enforcing coherent, ethical and compliant internal AI policies for different applications throughout the business while managing different risk appetites
- Harness AI’s potential to streamline operations, automate tasks and optimise internal audits to enhance compliance functions’ efficiency
- We all know the risks of AI – what is the level of resourcing required to minimise threats, secure vulnerabilities and ensure watertight compliance?
- Combat the ambiguity and uncertainty of AI’s evolution over time with consistent checks and validation to maintain control and ensure it remains fit for intended use
- Influence internal players to create responsible AI behaviours: governance processes, training and education to ensure awareness of blind spots, bias, security and patient safety
- As digital and AI explode across the business world, the GRC responsibility and complexity increases, how is the EU AI Act playing out in day-to-day several months down the line and what do we anticipate the next regulatory updates will focus on?
Jonathan Vogelsang, Ethics, Risk & Compliance Director International, Novartis Pharma AG
Moez Youssef, Ethics Risk & Compliance Global Director, Oncology, Novartis
Evgeny Tilezhinsky, Legal and Compliance Director, Kyowa Kirin International
VIEW THE FULL PROGRAMME
At Global Insight Conferences, we have exciting offers and news about our upcoming events that we hope you’d like to hear about! We will use your information to predict what you might be interested in. We will treat your data with respect and you can find the details of our privacy policy here. You can stop receiving our updates at any time.
Please remember to check your junk folder for the brochure – and add @gicconferences.com to your safe senders list.
